0.5393
price up icon1.68%   0.0089
pre-market  Pre-mercato:  .51   -0.0293   -5.43%
loading

Athira Pharma Inc Azioni (ATHA) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Research and Development
10.32%
21.24
23.68 27.20 21.61 21.29
Costs And Expenses
4.57%
27.69
29.01 35.04 31.64 29.77
Operating Income/Loss
4.57%
-27.69
-29.01 -35.04 -31.64 -29.77
Income/Loss From Continuing Operations Before Tax
3.47%
-26.34
-27.29 -35.04 -29.60 -27.82
Income/Loss From Continuing Operations After Tax
3.47%
-26.34
-27.29 -32.97 -29.60 -27.82
Net Income/Loss
3.47%
-26.34
-27.29 -32.97 -29.60 -27.82
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
140.89K%
38.32
0.0272 38.05 38.00 37.92
Diluted Average Shares
140.89K%
38.32
0.0272 38.05 38.00 37.92
Basic Earnings Per Share
2.82%
-0.69
-0.71 -0.87 -0.78 -0.73
Diluted Earnings Per Share
2.82%
-0.69
-0.71 -0.87 -0.78 -0.73
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$21.80
price up icon 4.81%
$73.47
price up icon 2.14%
$22.10
price up icon 16.13%
$367.97
price up icon 2.52%
biotechnology ONC
$218.70
price up icon 4.10%
$117.25
price up icon 4.75%
Capitalizzazione:     |  Volume (24 ore):